A new publication involving afamelanotide appeared on September 1, 2026. The paper, titled "Acute impact of afamelanotide on UVR erythemal and melanogenic responses in healthy humans in vivo: an exploratory study," was published in Photochemical & Photobiological Sciences, the official journal of the European Photochemistry Association and the European Society for Photobiology.
The publication is described as an exploratory study examining afamelanotide in the context of ultraviolet radiation exposure in healthy human participants. No specific findings, outcomes, or conclusions from the study were included in the available event data.
Afamelanotide is an approved compound. This publication adds to the existing body of literature on the compound, as indexed under PubMed ID 42678656.
Readers interested in the broader context of this compound, including its approved uses and prior research, can consult the compound overview for further background.